What is Cefaclor used for?

Cefaclor is a second-generation cephalosporin antibiotic that has gained recognition in the medical community for its efficacy in treating a variety of bacterial infections. Also known by its trade names Ceclor, Raniclor, and Distaclor, cefaclor targets bacterial cell walls and is used to treat infections in the ears, lungs, skin, throat, and urinary tract. Developed initially by pharmaceutical companies like Eli Lilly and Company, cefaclor has undergone extensive research and clinical trials to establish its safety and effectiveness. Over the years, it has become a trusted antibiotic prescribed by healthcare providers for its broad-spectrum antibacterial activity.

The primary indication for cefaclor is its use in treating bacterial infections such as otitis media (middle ear infections), lower respiratory tract infections (like pneumonia and bronchitis), pharyngitis, tonsillitis, sinusitis, and uncomplicated skin and skin structure infections. It is also employed in treating urinary tract infections. Research institutions worldwide have extensively studied cefaclor to understand its pharmacodynamics, optimal dosages, and resistance patterns. The drug's approval by the U.S. Food and Drug Administration (FDA) and other regulatory agencies globally has cemented its place in the therapeutic arsenal against bacterial infections.

 

Researching Cefaclor beyond the basics?

Synapse Hiro LS Researcher, the Synapse AI Insight Engine, is built to accelerate biopharma decisions. Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence. Explore Cefaclor with Hiro LS Researcher →

Cefaclor works by inhibiting the synthesis of the bacterial cell wall, which is essential for bacteria's survival. Specifically, it binds to penicillin-binding proteins (PBPs) located inside the bacterial cell wall. These proteins play a critical role in the last stages of cell wall assembly and reshaping during bacterial growth and division. By binding to PBPs, cefaclor hinders the cross-linking of peptidoglycan strands, which are crucial components of the bacterial cell wall. This disruption leads to cell lysis and ultimately the death of the bacterial cell. The mechanism of action of cefaclor is bactericidal, meaning it kills bacteria rather than merely inhibiting their growth. This attribute makes it particularly effective against actively dividing bacteria.

Cefaclor is typically administered orally in capsule, tablet, or suspension form. The standard dosage and length of treatment depend on the type and severity of the infection, as well as the patient's age, weight, and kidney function. For adults, the usual dosage ranges from 250 mg to 500 mg taken every 8 hours, while children’s dosages are based on their body weight and are usually administered in a liquid suspension. The onset of action for cefaclor is relatively quick, with therapeutic levels reached in the bloodstream within 30 to 60 minutes after oral administration. It is important to complete the full course of cefaclor as prescribed by a healthcare provider, even if symptoms improve before the medication is finished. This helps to ensure the complete eradication of the bacteria and reduces the risk of developing antibiotic-resistant strains.

Like all medications, cefaclor can cause side effects, although not everyone will experience them. Common side effects include gastrointestinal issues such as nausea, vomiting, diarrhea, and abdominal pain. Allergic reactions, though less common, can occur and may manifest as rash, itching, swelling, dizziness, or trouble breathing. Severe allergic reactions, including anaphylaxis, are rare but require immediate medical attention. Other potential side effects include headache, dizziness, and, in some cases, changes in blood counts (such as decreased white blood cells or platelets).

Cefaclor is contraindicated in individuals with a known hypersensitivity to cephalosporins or any component of the formulation. Caution is also advised for those with a history of penicillin allergy, as cross-reactivity may occur. Patients with a history of gastrointestinal diseases, particularly colitis, should use cefaclor with caution due to the potential risk of Clostridium difficile-associated diarrhea. It is also essential to adjust the dosage for patients with renal impairment to prevent drug accumulation and toxicity.

Several drugs can interact with cefaclor, affecting its efficacy and safety. For instance, probenecid, a medication used to treat gout, can increase the concentration of cefaclor in the blood by inhibiting its renal excretion. This interaction may enhance the therapeutic effect of cefaclor but also increases the risk of side effects. Antacids containing aluminum or magnesium may reduce the absorption of cefaclor, potentially diminishing its effectiveness. Therefore, it is advisable to take cefaclor at least one hour before or two hours after antacids.

Additionally, warfarin, a blood thinner, may have its anticoagulant effects potentiated when used concomitantly with cefaclor, increasing the risk of bleeding. Regular monitoring of blood coagulation parameters is recommended when these medications are used together. Oral contraceptives may also be less effective when taken with cefaclor, so alternative or additional contraceptive measures should be considered.

In conclusion, cefaclor is a versatile and effective antibiotic widely used to treat various bacterial infections. Understanding its mechanism of action, proper administration methods, potential side effects, and drug interactions is essential for maximizing its therapeutic benefits and minimizing risks. As with any medication, it is crucial to follow the healthcare provider’s instructions and report any adverse effects or concerns promptly to ensure safe and effective treatment.

Continue your Cefaclor research with Synapse Hiro LS Researcher

This article provides an overview. For a broader research view, use Synapse Hiro LS Researcher—the Synapse AI Insight Engine—to search across drugs, targets, indications, clinical trials, literature, organizations, news, deals, and competitor signals. Ask any biopharma research question in natural language.

Questions to explore:

• What approved and investigational uses have been reported for Cefaclor?
• What is the mechanism of action of Cefaclor, and which targets or pathways are involved?
• Which clinical trials are evaluating Cefaclor, and what outcomes have been reported?
• What patents, publications, and regulatory sources provide the latest evidence on Cefaclor?

Ask Synapse Hiro LS Researcher →

AI may make mistakes. Check important info.